Carlo Franco Medina Ramirez

Dr. Carlo Franco Medina Ramirez

UANL
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2020 in Fermentation
Verified
Journal Article
Open access
PDF file
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
MCMariana Teresa Castañeda-Guel
Mariana Teresa Castañeda-Guel
MAMa. Fernanda Alvarez-Gonzalez
Ma. Fernanda Alvarez-Gonzalez
AMAlejandro Montesinos-Castellanos
Alejandro Montesinos-Castellanos
JMJosé Ruben Morones-Ramírez
José Ruben Morones-Ramírez
AGAlma Gómez
Alma Gómez
Exopolysaccharides (EPS) are high molecular weight biomaterials of industrial interest due to their variety of applications in the pharmaceutical, cosmetic, environmental, and food industries. EPS produced by Rhodotorula mucilaginosa UANL-001 L has sparked interest due to its bio-adsorbent and wide spectrum antimicrobial properties. However, full exploitation and commercial application of EPS has been restrained due to low yields and high production costs. In the present work, the production and separation of EPS from Rhodotorula mucilaginosa UANL-001L was attempted through extractive fermentation in order to increase EPS production while simplifying the recovery process. Extractive fermentation was implemented with a thermoseparating polymer for phase formation (EOPO 970 and EOPO 12,000); culture viability, biomass generation, EPS production, rheological system properties, and phase formation time and temperature were monitored throughout the process. Extractive fermentation of Rhodotorula mucilaginosa UANL-001L with EOPO 970 resulted in a 42% EPS and 7% biomass recovery on the top phase after 5 to 13-min phase formation time and temperatures between 30 and 40 °C. This is the first report of extractive fermentation application for EPS production by yeast of the genera Rhodotorula, resulting in an interesting strategy for EPS production and recovery, although further optimization is needed.

25 October 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
LRLuis Mario Rodríguez-Martínez
Luis Mario Rodríguez-Martínez
JCJose Luis Chavelas-Reyes
Jose Luis Chavelas-Reyes
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
ECEli de Jesús Fuentes Chávez
Eli de Jesús Fuentes Chávez
ZMZurisaday Sheccid Muñoz
Zurisaday Sheccid Muñoz
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
Tuberculosis (TB), caused by Mycobacterium tuberculosis, continues to be a leading cause of morbidity and mortality in Mexico, with more than 20,000 new cases annually and a rising proportion of drug-resistant strains. This work addresses the molecular epidemiology of TB in the Mexican context, emphasizing its role in understanding transmission, genetic diversity, and resistance mechanisms. To achieve this, we reviewed molecular typing approaches including spoligotyping, Mycobacterial Interspersed Repetitive Unit–Variable Number Tandem Repeat (MIRU-VNTR) analysis, and whole-genome sequencing (WGS), which have been applied to characterize circulating lineages and identify drug-resistance-associated mutations. The results indicate that the Euro-American lineage (L4) predominates across the country, although significant regional variation exists, with Haarlem, LAM, T, and X sub lineages dominating in different states, and occasional detection of Asian (L2) and Indo-Oceanic (L1) lineages. Key resistance mutations were identified in katG, rpoB, pncA, and gyrA, contributing to the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains, particularly in border and marginalized regions. These findings highlight how social factors, such as migration, urban overcrowding, and comorbidities including diabetes and HIV, influence transmission dynamics. We conclude that integrating molecular tools with epidemiological surveillance is crucial for strengthening public health strategies and guiding interventions tailored to Mexico’s heterogeneous TB burden.

11 March 2026 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
LRLuis Mario Rodríguez-Martínez
Luis Mario Rodríguez-Martínez
JCJose Luis Chavelas-Reyes
Jose Luis Chavelas-Reyes
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
JVJorge A. Valdés-González
Jorge A. Valdés-González
ECEli de Jesús Fuentes Chávez
Eli de Jesús Fuentes Chávez
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, remains one of the most relevant zoonotic diseases worldwide due to its dual impact on livestock production and human health. Although zoonotic tuberculosis has been virtually eradicated from cattle in a few settings, particularly in Australia, the disease persists in much of Latin America, Africa, and Asia, where it continues to limit cattle productivity and pose a threat to public health through the consumption of unpasteurized dairy products and occupational exposure. This review integrates historical, epidemiological, clinical, and molecular perspectives of bTB, with particular emphasis on Mexico, highlighting the role of wildlife reservoirs, socioeconomic factors, and diagnostic limitations in maintaining endemicity. Recent advances in molecular epidemiology, such as PCR, MIRU-VNTR, and whole-genome sequencing, provide promising avenues for surveillance and control. Finally, we discuss the importance of adopting a One Health framework that bridges veterinary, medical, and environmental approaches to achieve sustainable control of this silent zoonosis.

17 June 2024 in Microbiology Research
Verified
Journal Article
Open access
PDF file
LRLuis M. Rodríguez-Martínez
Luis M. Rodríguez-Martínez
JCJose Luis Chavelas-Reyes
Jose Luis Chavelas-Reyes
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
FCFrancisco Joel Cabrera-Santos
Francisco Joel Cabrera-Santos
NFNadia A. Fernández-Santos
Nadia A. Fernández-Santos
MRMario A. Rodríguez-Pérez
Mario A. Rodríguez-Pérez
COVID-19 is no longer a public health emergency of international concern, but long COVID’s effects are yet to be fully understood. Hence, globally, SARS-CoV-2 is still a profound threat to public health and of perilous nature as a zoonotic disease. Timely vaccination provided to individuals worldwide during the pandemic phase was under a certain degree of control; however, few studies have reported the effectiveness of vaccines administered in Mexico, and its surveillance is paramount. Furthermore, an unknown proportion of Mexican individuals have not yet received any vaccine, and the circulation of the Omicron, Pirola, and FLiRT variants is ongoing. A cross-sectional serology survey study design was employed, involving 150 individuals from Southern Mexico (Oaxaca) whose humoral immune responses after vaccination were tested by an ELISA; the receptor-binding domain of the SARS-CoV-2 spike protein served as a recombinant antigen in the ELISA. One hundred thirty-nine out of 150 individuals (92.6%; 95%-CI = 87–95%) examined were positive for the ELISA, but in 11 individuals, the vaccines did not induce any immune response. Interestingly, the immune responses (antibody prevalence and levels) of females (58%) were higher (T= −2.21; p-value = 0.02) than those of males (41%). However, in this sample population of Southern Mexico, age, vaccine type, comorbidity, and body mass index did not have any effect (p > 0.05) after COVID-19 vaccination. Taking all results together, here, we present factors that affected immune responses of individuals during the first vaccination campaign in Oaxaca, Mexico; however, vaccine surveillance during the post-pandemic phase needs further investigation.

2 July 2026
Verified
Book Chapter
Closed access
PDF file
LMLuis Mario Rodríguez Martínez
Luis Mario Rodríguez Martínez
LMLuis Mario
Luis Mario
RGRodríguez- González
Rodríguez- González
JGJosefina Guadalupe
Josefina Guadalupe
CRCarlos Antonio Ríos-Saldaña
Carlos Antonio Ríos-Saldaña
MAMario Alberto
Mario Alberto

Verified
Journal Article
Open access
PDF file
CRCarlo Franco Medina Ramirez
Carlo Franco Medina Ramirez
JCJose L. Chavelas-Reyes
Jose L. Chavelas-Reyes
JRJosefina G. Rodríguez-González
Josefina G. Rodríguez-González
NFNadia A. Fernández-Santos
Nadia A. Fernández-Santos
LWLihua Wei
Lihua Wei
MRMario A. Rodríguez-Pérez
Mario A. Rodríguez-Pérez
Understanding the molecular mechanisms underlying host immune responses to SARS-CoV-2 vaccination remains essential, particularly in populations with a high prevalence of obesity. In this cross-sectional study, we evaluated whether body mass index (BMI) is associated with vaccine-induced humoral immunity in a cohort from northeastern Mexico and discuss the findings within a structural immunology framework of spike antigenicity and antibody–epitope interactions. A total of 138 adults were recruited in Reynosa and Matamoros (June 2021–June 2022) and categorized as healthy weight, overweight, or obese according to BMI criteria. Serum anti-SARS-CoV-2 IgG was assessed using an ELISA-based assay, and differences across BMI groups were tested using the Kruskal–Wallis approach. Among all participants, 33.3% were classified as obese and 99.3% (137/138) were seropositive for anti-SARS-CoV-2 IgG. No significant differences in IgG levels were detected between BMI categories (p = 0.20). These results indicate that, in this Mexican cohort—sampled during a period of heterogeneous and often incomplete vaccination schedules—obesity was not associated with reduced detectable anti-SARS-CoV-2 IgG responses. Our findings support the need to integrate population-level serology with mechanistic studies that interrogate antibody quality (e.g., neutralization potency and epitope specificity) to better connect clinical determinants such as obesity with molecular correlates of protection.